Researchers are developing mRNA vaccines against HIV, and one method has recently shown promising preliminary results in animal and human experiments. (Image credit: Catherine Falls Advertising via Getty Images)
New HIV vaccines have shown encouraging results in studies involving laboratory animals and human volunteers, suggesting a potential way to prevent the chronic viral disease.
These experimental vaccines are based on mRNA technology and have produced a range of powerful immune responses in early trials, while showing minimal side effects.
The scientists described the new vaccines in two papers published Wednesday (July 30) in the journal Science Translational Medicine. The first study tested several vaccines in rabbits and monkeys, and promising results from that work led to further development of the vaccines and subsequent testing in humans. The study involved more than 100 healthy volunteers and tested three vaccines similar to those used in the animals.
You may like
-
'Universal' cancer vaccine heading to human trials could be useful for 'all forms of cancer'
-
'2-in-1' COVID-19 flu vaccine shows promise, but approval could be delayed
Sourse: www.livescience.com
